M1 phenotypes have now been replaced by M(Lipopolysaccharides (LPS) + Interferon Type II (IFN Type II) / Interferon Gamma (IFN-g)) (M(LPS + IFN-g))
M1-like genes are inos, ilb1 gene, mhcII, and cd80 gene.
M1 macrophages (CD68+ iNOS+) are activated by a polarization signal from bacterial lipopolysaccharides (LPS) and pro-inflammatory Th1 cytokines such as Interferon Type II (IFN Type II) / Interferon Gamma (IFN-g), Tumor Necrosis Factor alfa (TNF-alfa), and Interleukin-1 (IL-1) beta (IL-1F2)
Glucose utilization and the production of chemical mediators such as ATP, reactive oxygen species (ROS), nitric oxide (NO), and NADPH support the effector activities of M1 macrophages (CD68+ iNOS+)
M1 macrophages is characterized by a high production of pro-inflammatory cytokines (Tumor Necrosis Factor alfa (TNF-alfa), Interleukin-1 (IL-1) beta (IL-1F2), Interleukin-6 (IL-6), Chemokine (C-X-C motif) ligand 8 (CXCL8) / Interleukin-8 (IL-8) and Interleukin-12 (IL-12)).
M1 phenotype is triggered by polarization signal from bacterial lipopolysaccharide (LPS) and Th1 pro-inflammatory cytokines such as interferon-gamma , TNF-alfa, and IL-1 beta , or both
M1 cells display Th1-oriented pro-inflammatory effector properties and promote tissue damage and antimicrobial and antitumor resistance
M1 macrophages or classically activated macrophages serve to defend against bacterial and viral infections and tumor regression.
The M1 phenotype is characterized by a high production of pro-inflammatory cytokines, such as Tumor Necrosis Factor alfa (TNF-alfa), Interleukin-1 (IL-1) beta (IL-1F2), Interleukin-6 (IL-6), Chemokine (C-X-C motif) ligand 8 (CXCL8) / Interleukin-8 (IL-8) and Interleukin-12 (IL-12), and by expression of pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs)
M1 macrophages produce high levels of Type I cytokines that promote a tumor-rejecting Type 1 response
see also:
CD14++ CD16− Monocytes & Toll-like receptors (TLRs)
Immune cell metabolism / Immunometabolism
Localisation / Occurence & Toll-like receptors (TLRs)
M1 polarization
M1 macrophages (CD68+ iNOS+) & Tumor Necrosis Factor alfa (TNF-alfa)
Geplant: 28.10.2025, 07:30 bis 08:00, MEZ & Tumor Necrosis Factor alfa (TNF-alfa)
Localisation / Occurence & Pattern Recognition Receptors (PRRs)
THP-1 cell line